Sidley Austin LLP advised Viva Biotech Holdings on the transaction. Viva Biotech Holdings (HKEX: 1873) has successfully issued US$180 million of guaranteed convertible bonds due 2025…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
